UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10679

2022

Volltextzugriff (PDF)

PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model

PloS one, 2012-06, Vol.7 (6), p.e39179

2012

Volltextzugriff (PDF)

Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies

The Journal of clinical investigation, 2022-06, Vol.132 (12), p.1-12

2022

Volltextzugriff (PDF)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection

Journal of translational medicine, 2021-06, Vol.19 (1), p.272-272, Article 272

2021

Volltextzugriff (PDF)

G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma

Nature communications, 2023-02, Vol.14 (1), p.563-563, Article 563

2023

Volltextzugriff (PDF)

Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults

The Journal of clinical investigation, 2023-07, Vol.133 (13), p.1-12

2023

Volltextzugriff (PDF)

Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma

PloS one, 2012-03, Vol.7 (3), p.e32493

2012

Volltextzugriff (PDF)

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Scientific reports, 2023-10, Vol.13 (1), p.17337-17337, Article 17337

2023

Volltextzugriff (PDF)

Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer

Cells (Basel, Switzerland), 2021-07, Vol.10 (8), p.1861

2021

Volltextzugriff (PDF)

The host-pathogen interaction during HBV infection: immunological controversies

Antiviral therapy, 2010-01, Vol.15 Suppl 3 (3_suppl), p.15-24

2010

Volltextzugriff (PDF)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels

PloS one, 2013-06, Vol.8 (6), p.e65327-e65327

2013

Volltextzugriff (PDF)

SARS‐CoV‐2 clearance after breakthrough infection correlates with fit and happy T cells

Immunology and cell biology, 2023-08, Vol.101 (7), p.587-589

2023

Volltextzugriff (PDF)

Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling

Nature communications, 2018-07, Vol.9 (1), p.2716-13, Article 2716

2018

Volltextzugriff (PDF)

A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance

PloS one, 2014-07, Vol.9 (7), p.e101904-e101904

2014

Volltextzugriff (PDF)

Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes

PloS one, 2011-12, Vol.6 (12), p.e29300-e29300

2011

Volltextzugriff (PDF)

SARS-CoV-2-specific T cells in infection and vaccination

Cellular & molecular immunology, 2021-10, Vol.18 (10), p.2307-2312

2021

Volltextzugriff (PDF)

Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands

PloS one, 2012-01, Vol.7 (1), p.e29286-e29286

2012

Volltextzugriff (PDF)

Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

PloS one, 2011-08, Vol.6 (8), p.e23330-e23330

2011

Volltextzugriff (PDF)

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nature (London), 2020-08, Vol.584 (7821), p.457-462

2020

Volltextzugriff (PDF)

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.3177-3188

2017

Volltextzugriff (PDF)

Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes

PloS one, 2012-12, Vol.7 (12), p.e51397-e51397

2012

Volltextzugriff (PDF)

Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition

Seminars in immunopathology, 2021-08, Vol.43 (4), p.535-548

2021

Volltextzugriff (PDF)

HBV antiviral immunity: not all CD8 T cells are born equal

Gut, 2019-05, Vol.68 (5), p.770-773

2019

Volltextzugriff (PDF)

Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply

The Journal of clinical investigation, 2021-12, Vol.131 (24), p.1-1

2021

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaLymphocytes T

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Humans
(34)
Lymphocytes
(33)
Life Sciences & Biomedicine
(27)
Infections
(20)
Hepatitis B
(19)
Antigens
(18)
Immunology
(17)
T Cell Receptors
(17)
Patients
(16)
Hepatitis
(15)
Multidisciplinary Sciences
(15)
Science & Technology - Other Topics
(15)
Viruses
(15)
Cd8 Antigen
(14)
Severe Acute Respiratory Syndrome Coronavirus 2
(14)
Chronic Infection
(13)
Cytokines
(13)
Hepatitis B Virus
(12)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization

PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model

Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection

G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma

Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults

Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer

The host-pathogen interaction during HBV infection: immunological controversies

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels

SARS‐CoV‐2 clearance after breakthrough infection correlates with fit and happy T cells

Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling

A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance

Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes

SARS-CoV-2-specific T cells in infection and vaccination

Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands

Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection

Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes

Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition

HBV antiviral immunity: not all CD8 T cells are born equal

Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply

Dynamics and genomic landscape of CD8 + T cells undergoing hepatic priming

Aktive Filter

Suchergebnisse filtern